Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2010
08/18/2010CN101804038A Huperzine A preparation for treating schizophrenia and nervous function damage and preparation method thereof
08/18/2010CN101804037A Acyclovir dispersible tablet and preparation method thereof
08/18/2010CN101804036A 多潘立酮口腔崩解片及其制备方法 Domperidone orally disintegrating tablets and its preparation method
08/18/2010CN101804035A Lansoprazole preparation for injection and preparation method thereof
08/18/2010CN101804034A Rabeprazole sodium powder injection and preparation method thereof
08/18/2010CN101804033A Atenolol non-pH-dependent sustained release pellets and preparation method thereof
08/18/2010CN101804032A Preparation method of 5-fluorouracil-wrapped biodegradable polylactic acid/nano-hydroxyapatite compound microspheres
08/18/2010CN101804031A Preparation method of ribavirin-quaternized chitosan nanoparticles
08/18/2010CN101804030A Sodium dichlorophenolate micro-pill pharmaceutical preparation and preparation method thereof
08/18/2010CN101804029A Atorvastatin liposome and preparation method thereof, and medicine composition containing atorvastatin
08/18/2010CN101804028A Method for preparing traditional Chinese medicine liposome
08/18/2010CN101804027A Granisetron hydrochloride nasal spray and preparation method thereof
08/18/2010CN101804025A Aqueous solution injection for picoplatin
08/18/2010CN101804024A Gel taking 2beta, 3beta, 12,13-tetrahydroxy-oleanane-28-acid as active component
08/18/2010CN101804023A Gel taking 2alpha, 3beta, 12,13-tetrahydroxy-oleanane-28-carboxylate methyl ester as active component
08/18/2010CN101804022A Gel taking 2alpha, 3beta, 12,13-tetrahydroxy-oleanane-28-acid as active component
08/18/2010CN101804021A Preparation method of polyene-containing taxol nanoparticle mixed micelle preparation and freeze-drying agent
08/18/2010CN101803821A Treatment of skin with apparatus and benefit agent
08/18/2010CN101623263B Cefminox sodium liposome preparation
08/18/2010CN101623260B Cefepime hydrochloride proliposome preparation
08/18/2010CN101601656B Edaravone liposome injection and new application thereof
08/18/2010CN101601654B Hydrochloric acid Fasudil liposome injection and new application thereof
08/18/2010CN101570521B Preparation method and medical application of 4-tert-butyl-6-phenyl-2-amino-6H-1,3-thiazine salt
08/18/2010CN101548957B Sub-micro emulsion frozen preparation of pantoprazole sodium prepared by using multiple emulsion method
08/18/2010CN101548956B Sub-micro emulsion frozen preparation of aztreonam
08/18/2010CN101536995B High imbibition dissoluble drug release external contraceptive membrane
08/18/2010CN101513401B Application of beta-m-dihydroxy-benzoic acid macrocyclic lactone derivative in prevention of malaria
08/18/2010CN101507723B Combination medicine capable of treating pneumonia and upper respiratory tract infection and preparation method thereof
08/18/2010CN101474176B Pharmaceutical composition of flucloxacillin sodium and amoxicillin sodium and production method thereof
08/18/2010CN101416944B Sodium ferulic acid nano micelle preparation and preparation method thereof
08/18/2010CN101381372B Pazufloxacin mesylate and preparation method of powder for injection
08/18/2010CN101367819B 5-substituent-2-(4-substituted phenyl)-6,7-dihydrogen pyrazole-[1,5-a]pyrazine-4(5H)-ketone derivant and uses thereof
08/18/2010CN101348569B Organotin coordination polymeric compound, preparation and use thereof
08/18/2010CN101348493B High-purity medicament and preparation thereof
08/18/2010CN101342158B Application of two bromine phenolic compounds in preparing medicament for treating malignant tumor
08/18/2010CN101322702B Piperacillin sodium and sulbactam sodium for injection and preparation of freeze-dried injection thereof
08/18/2010CN101322701B Amoxicillin sodium and sulbactam sodium for injection and preparation of freeze-dried injection thereof
08/18/2010CN101305997B Medicament for treating nerve dysfunction after refraining opium type material
08/18/2010CN101284861B Triterpenoid saponin compounds, preparation method and use
08/18/2010CN101284011B Oleanolic acid orally disintegrating tablet and preparation method thereof
08/18/2010CN101278913B Novel polyethylene glycol-phospholipid entrapped prostaglandin E1 micelle preparation
08/18/2010CN101254178B Gliclazide controlled release tablets
08/18/2010CN101249173B Traditional Chinese medicine preparation for curing gout and method of preparing the same
08/18/2010CN101244135B Medicine label for treating rheumatism, hyperosteogeny
08/18/2010CN101234102B Peperphentonamine hydrochloride freeze-dried injection and preparation and application thereof
08/18/2010CN101199507B Application of furan diene and derivatives in preparing therapeautic cancer medicament
08/18/2010CN101195647B Hydroxyl carthamus tinctorius yellow colour A, preparation method and application thereof
08/18/2010CN101195008B Cattail pollen skin cleaning agent for treating gynecology disease and technique of preparing the same thereof
08/18/2010CN101172975B Method of preparing five-alkaloid composition of corydalis saxicola bunting
08/18/2010CN101167741B Sulforaphane and platinum medicine anti-cancer combination preparation
08/18/2010CN101164534B Application of curcumin in preparing tumor multi-medicine drug-resistant prevention agent
08/18/2010CN101160128B Protective agent for retinal neuronal cell comprising indazole derivative as active ingredient
08/18/2010CN101113130B Method for preparing high-purity hypocrellin A
08/18/2010CN101103994B Medicine for preventing and treating gout and hyperuricemia
08/18/2010CN101099737B Medicine for treating trypanosome disease
08/18/2010CN101092363B Compound of lignanin aryl tetrahydronaphthalene, preparation method and application
08/18/2010CN101087613B Preventing or treating agent for glaucoma
08/18/2010CN101077403B Plaster for treating retention of food and dysmenorrhea
08/18/2010CN101024671B 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors
08/18/2010CN100998640B Medicine for treating burns and scald, and its preparing method
08/17/2010US7779020 Small-footprint applicative query interpreter method, system and program product
08/17/2010US7777069 Prodrugs of carbamate inhibitors of IMPDH
08/17/2010US7777060 Cis-(3-[2-(2-cyano-ethoxy)-ethoxy]-propionitrile)dichloroplatinum (II); Cis-bis(3-methoxy-propionitrile)dichloroplatinum (II); lipophilicity; modulate replication or transcription of DNA or translation or function of RNA; anticancer agents
08/17/2010US7777058 A thrombolytic agent in combination with a compound such as2-methylthioisosorbide 5-mononitrate; cardiovascular diseases such as, atherosclerosis, cardiac allograft vasculopathy, and tissue damage due to ischemia and/or to ischemia-reperfusion
08/17/2010US7777057 Derivatives of dioxan-2-alkyl carbamates, preparation thereof and application thereof in therapeutics
08/17/2010US7777051 A compound with azo containing mono and a bicyclic rings attached with an aryl or heteroaryl ring; both therapeutic and diagnostic
08/17/2010US7777050 N3 alkylated benzimidazole derivatives as MEK inhibitors
08/17/2010US7777042 N-sulfonylpipecolic acid derivative FKBP binding composition and pharmaceutical use thereof
08/17/2010US7777034 Crystalline ammonium salts of rosuvastatin
08/17/2010US7777030 1,3,5-triazepan-2,6-diones synthesized by cyclization of simple activated dipeptide derivatives; for the treatment of malaria
08/17/2010US7777027 Purified beta glucan composition
08/17/2010US7776925 Nitroglycerin therapy and reactive oxygen and blood monitoring
08/17/2010US7776924 for gene-dependent enzyme prodrug therapy (GDEPT) and cell ablation therapy in conjunction with nitroreductase enzymes as hypoxia selective cytotoxins and as anticarcinogenic agents; 2((2-Bromoethyl)-2-{[(2-hydroxyethyl)amino]carbonyl}-4,6-dinitroanilino)ethyl methanesulfonate
08/17/2010US7776923 Use of 2E,4E-decadienoic acid isobutylamide for imparting a salivation inducing effect to a foodstuff, an oral hygiene preparation or a gourmet or snack preparation; preparation by amidating a dodecadienoate with isobutylamine
08/17/2010US7776922 Substituted [(phenylethanoyl)amino]benzamides
08/17/2010US7776921 Treating benign prostate hyperplasia with SARMS
08/17/2010US7776920 such as N'-[2-(3,4-Difluorophenyl)-2-hydroxyacetyl]-2,4- dihydroxy-6-methylbenzohydrazide, having human serum and glucocorticoid dependent kinase inhibitory activity, for the treatment of diabetes, obesity, dyslipidemia, hypertonia, cardiovascular and kidney diseases, fibrosis and inflammatory processes
08/17/2010US7776919 modulators of the interaction between the receptor for advanced glycated end products; 3-(4-Benzyloxyphenyl)propionic Acid 2,4- Di-(3-Diethylamino-1-propoxy)aniline Amide; acute and chronic inflammation; diabetic late complications; Alzheimer's disease, erectile dysfunction; metastasis
08/17/2010US7776918 Remedy for viral disease
08/17/2010US7776917 Non-standard amino acid conjugates of amphetamine and processes for making and using the same
08/17/2010US7776916 Nitrated lipids and methods of making and using thereof
08/17/2010US7776915 a lipoic acid, a carnitine, and a carnosine in a suitable vehicle for topical application for treating skin; useful in improving the appearance of aged skin characterized by wrinkles and loss of elasticity; preferred components include R-lipoic acid or R-dihydrolipoic acid, acetyl-1-carnitine,1-carnosin
08/17/2010US7776914 antiinflammatory agent contains lecithin fatty acid, olive oil fatty acid, esterified fatty acid and vitamin E; prevents arthritis and other inflammatory disorders, reduced side effects associated with renal and cardiovascular dysfunction, reduced production of arachidonic acid in cells; nutraceuticals
08/17/2010US7776913 treating the symptoms of disorders caused by andropause wherein symptoms are selected from reduced libido or sexual drive and reduced quality of erections, depression of mood, and fatigue by administering L-carnitine, propionyl L-carnitine and/or acetyl L-carnitine
08/17/2010US7776911 Antimalarial drug containing synergistic combination of curcumin and artemisinin
08/17/2010US7776910 Piperazinyl-substituted quinolinone compounds ;to treat nervous system diseases, neurodegenerative diseases; gastrointestinal tract disorders; cognition enhancers; 3-[4-(3-Ethylsulfanyl-benzenesulfonyl)-2-methoxy-phenyl]-pyrrolidine and 5-(3-Ethylsulfanyl-benzenesulfonyl)-2-pyrrolidin-3-yl-phenol
08/17/2010US7776909 such as (5-acetyl-1-methyl-1H-pyrrol-2-yl)acetyl methanesulphonamide, used for the of treatment of psoriasis, ulcerative colitis, melanoma, chronic obstructive pulmonary disease (COPD), skin disorders, rheumatoid arthritis, idiopathic fibrosis, glomerulonephritis and reperfusion injuries after ischemia
08/17/2010US7776908 Use in inhibiting PI-3-kinase activity in mammals; cancer; Acetic acid 4-diallylaminomethylene-6-hydroxy-1- alpha -methoxymeth-yl-10 beta ,13 beta -dimethyl-3,7,17-trioxo-1,3,4,7,10,11 beta , 12,13,14 alpha ,15,16,17-dodecahydro-2-oxa-cyclopenta[ alpha ]phenanthren-11-yl ester
08/17/2010US7776907 Methods for the treatment and management of macular degeneration using cyclopropyl-N-{2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-3-oxoisoindoline-4-yl}carboxamide
08/17/2010US7776906 Fungicidal active compound combinations
08/17/2010US7776905 including Cystic Fibrosis Transmembrane Conductance Regulator ("CFTR"), such as 1-(Benzo[d][1,3]dioxol-5-yl)-N-(2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide, used for the treatment of genetic disorders such as cystic fibrosis, emphysema, hemochromatosis and protein C deficiency
08/17/2010US7776904 N-{4-[(1S,5R/1R,5S)-3-azabicyclo[3.1.0]hex-1-yl]phenyl}-4-(1-methylethyl)benzenesulfonamide, used for treating drug abuse and dependence, schizophrenia , sexual disorders and as cognition activators
08/17/2010US7776903 Pharmaceutical preparations containing substituted 2,5-diaminomethyl-1H-pyrroles
08/17/2010US7776902 N-[4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]phenylsulfonyl]-4-nitrooxybutanamide, used for the treatment of inflammatory, cardiovascular, gastrointestinal, respiratory and nervous system disorders, as analgesics, antipyretics and antocoagulants or for organ and tissue preservation
08/17/2010US7776901 4-(6-spiro-1'-Cyclopropane-1a,6-dihydro-1H-cyclopropa[a]inden-6a-yl)-1H-imidazole, used for the treatment where the memory deficiency is associated with Alzheimer's disease and memory deficiency induced by scopolamine; side effect reduction
08/17/2010US7776900 gamma--aminobutyric acid A (GABAA) receptor modulators such as 1-[3-(Pyridin-2-ylmethoxymethyl)-phenyl]-1H-benzoimidazole-5-carboxylic acid ethyl ester, useful in the treatment of central nervous system diseases and disorders; anxiolytic agents; side effect reduction
08/17/2010US7776899 Mixture of phentolamine mesylate, papaverine hydrochloride and alprostadil with buffer; injecting into penis
08/17/2010US7776898 Opioid receptor active compounds
08/17/2010US7776897 such as 3-[1-(5-chloro-2-thienyl)cyclopenty]-5,6,7,8,9,10-hexahydro [1,2,4]triazolo[4,3-a]azocine, having a strong 11 beta -hydroxysteroid dehydrogenase type 1inhibitory activity and exhibiting an excellent blood-glucose level-lowering action, used for the therapy of diabetes and insulin resistance
08/17/2010US7776896 alpha -[hexahydro-5-hydroxy-4-(3-hydroxy-4-methyl-1-octenyl)-2H-cyclopenta[b]furan-2-ylidene]-1H-tetrazole-5-2E-pentanenitrile; inhibits release of Th-1 cytokines while sparing expression of Th-2 cytokines; viricide; respiratory diseases associated with influenza A viruses
1 ... 2133 2134 2135 2136 2137 2138 2139 2140 2141 2142 2143 2144 2145 2146 2147 2148 2149 2150 2151 2152 2153 ... 7860